MORGAN STANLEY PLC/CALL/STRYKER CORP./440/0.1/20.12.24 Share Price

Warrant

DE000MB5S5Y1

Real-time Bid/Ask 07:17:59 28/05/2024 pm IST
0.21 EUR / 0.25 EUR +21.05% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./440/0.1/20.12.24
Current month-38.71%
1 month-36.67%
Date Price Change
28/24/28 0.19 0.00%
27/24/27 0.19 -7.77%
24/24/24 0.206 +8.99%
23/24/23 0.189 -2.58%
22/24/22 0.194 +9.60%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 01:46 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MB5S5Y
ISINDE000MB5S5Y1
Date issued 21/04/2023
Strike 440 $
Maturity 20/12/2024 (206 Days)
Parity 10 : 1
Emission price 0.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.36
Lowest since issue 0.12
Spread 0.037
Spread %15.16%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.5 USD
Average target price
372.4 USD
Spread / Average Target
+10.97%
Consensus